Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRP is a good alternative to ILTA for treating mild patch-type alopecia areata, with similar effectiveness and fewer side effects.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

GLP-1 RA medications may be linked to hair loss.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Blocking mTORC1 reduces skin tumor growth in mice.

Short peptides show promise as a new treatment for hair regrowth.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Ritlecitinib is safe and may effectively treat alopecia areata.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Pulsed electric field treatment may help shrink untreated liver tumors.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Thymosin β4 helps with healing, inflammation, and organ protection.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

New psoriasis treatments are effective but come with side effects and risks.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.